GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (NAS:NTRB) » Definitions » Gross Profit

Nutriband (Nutriband) Gross Profit : $0.86 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Nutriband Gross Profit?

Nutriband's gross profit for the three months ended in Jan. 2024 was $0.18 Mil. Nutriband's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was $0.86 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Nutriband's gross profit for the three months ended in Jan. 2024 was $0.18 Mil. Nutriband's Revenue for the three months ended in Jan. 2024 was $0.53 Mil. Therefore, Nutriband's Gross Margin % for the quarter that ended in Jan. 2024 was 34.48%.

Nutriband had a gross margin of 34.48% for the quarter that ended in Jan. 2024 => Competition eroding margins

During the past 9 years, the highest Gross Margin % of Nutriband was 41.34%. The lowest was -47.98%. And the median was 34.46%.


Nutriband Gross Profit Historical Data

The historical data trend for Nutriband's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband Gross Profit Chart

Nutriband Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Gross Profit
Get a 7-Day Free Trial Premium Member Only -0.18 0.32 0.50 0.75 0.86

Nutriband Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.22 0.30 0.16 0.18

Competitive Comparison of Nutriband's Gross Profit

For the Biotechnology subindustry, Nutriband's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutriband's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nutriband's Gross Profit distribution charts can be found below:

* The bar in red indicates where Nutriband's Gross Profit falls into.



Nutriband Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Nutriband's Gross Profit for the fiscal year that ended in Jan. 2024 is calculated as

Gross Profit (A: Jan. 2024 )=Revenue - Cost of Goods Sold
=2.085 - 1.223
=0.86

Nutriband's Gross Profit for the quarter that ended in Jan. 2024 is calculated as

Gross Profit (Q: Jan. 2024 )=Revenue - Cost of Goods Sold
=0.525 - 0.344
=0.18

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.86 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Nutriband's Gross Margin % for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.18 / 0.525
=34.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Nutriband  (NAS:NTRB) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Nutriband had a gross margin of 34.48% for the quarter that ended in Jan. 2024 => Competition eroding margins


Nutriband Gross Profit Related Terms

Thank you for viewing the detailed overview of Nutriband's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband (Nutriband) Business Description

Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Executives
Michael Davidov director 60 EAST 42 STREET, NEW YORK NY 10165
Serguei Melnik director, 10 percent owner, officer: Chief Financial Officer
Gareth Sheridan director, 10 percent owner, officer: CEO 6064 CENTRAL COLLEGE RD., NEW ALBANY OH 43054
Vitalie Botgros director, 10 percent owner, officer: Chairman of the BOD GREGERSTR 36B, FISHAMEND C4 2401